Van Hulzen Asset Management, LLC Pfizer Inc Transaction History

Van Hulzen Asset Management, LLC

$1.38 Billion
Q3 2024

A detailed history of Van Hulzen Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 32,947 shares of PFE stock, worth $868,482. This represents 0.07% of its overall portfolio holdings.

Number of Shares

32,947

Previous 28,206 16.81%

Holding current value

$868,482

Previous $789,000 20.79%

% of portfolio

0.07%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $131,325 - $148,819	4,741 Added 16.81%	32,947 $953,000
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $76,613 - $89,776	3,033 Added 12.05%	28,206 $789,000
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $37,411 - $42,959	-1,445 Reduced 5.43%	25,173 $699,000
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $4,546 - $5,905	-174 Reduced 0.65%	26,618 $766,000
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $1.07 Million - $1.25 Million	-33,342 Reduced 55.45%	26,792 $889,000
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $285,456 - $330,266	7,903 Added 15.13%	60,134 $2.21 Million
Q1 2023 Apr 28, 2023	BUY	$39.39 - $51.28 $1.1 Million - $1.44 Million	28,050 Added 116.0%	52,231 $2.13 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $47,010 - $61,367	1,126 Added 4.88%	24,181 $1.24 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $44,066 - $53,793	-1,007 Reduced 4.19%	23,055 $1.01 Million
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $28,150 - $33,377	605 Added 2.58%	24,062 $1.26 Million
Q1 2022 May 20, 2022	SELL	$45.75 - $56.69 $159,667 - $197,848	-3,490 Reduced 12.95%	23,457 $1.21 Million
Q4 2021 Feb 04, 2022	SELL	$41.32 - $61.25 $91,069 - $134,995	-2,204 Reduced 7.56%	26,947 $1.59 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $7,889 - $10,134	201 Added 0.69%	29,151 $1.25 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $189,425 - $214,587	5,275 Added 22.28%	28,950 $1.13 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $1.22 Million - $1.38 Million	-36,509 Reduced 60.66%	23,675 $858,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $5.98 Million - $7.6 Million	-178,579 Reduced 74.79%	60,184 $2.22 Million
Q3 2020 Nov 03, 2020	SELL	$31.75 - $37.25 $778,700 - $913,593	-24,526 Reduced 9.32%	238,763 $8.76 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $737,668 - $894,901	24,491 Added 10.26%	263,289 $8.61 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $396,935 - $567,134	14,685 Added 6.55%	238,798 $7.79 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $986,974 - $1.12 Million	29,981 Added 15.44%	224,113 $8.78 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $412,070 - $534,334	12,683 Added 6.99%	194,132 $6.98 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $861,042 - $966,751	23,284 Added 14.72%	181,449 $7.86 Million
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $5.17 Million - $5.68 Million	137,782 Added 675.97%	158,165 $6.72 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $3,731 - $4,254	-97 Reduced 0.47%	20,383 $890,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $3.95 Million - $4.79 Million	-114,644 Reduced 84.84%	20,480 $903,000
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $343,717 - $366,437	10,422 Added 8.36%	135,124 $4.9 Million
Q1 2018 May 08, 2018	BUY	$31.91 - $37.02 $1.09 Million - $1.26 Million	34,103 Added 37.64%	124,702 $4.43 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $20,787 - $22,056	-625 Reduced 0.69%	90,599 $3.28 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $156,705 - $172,628	5,055 Added 5.87%	91,224 $3.26 Million
Q2 2017 Aug 14, 2017	BUY	N/A	86,169	86,169 $2.89 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.

Account

Van Hulzen Asset Management, LLC Pfizer Inc Transaction History